Price $88.09 |
Market Cap
1.04B
|
Sector Health Care |
Div. Growth
13.20%
|
|
P/E
39.8
|
P/B
3.79
|
P/S
5.8
|
Dividend %
1.20%
|
|
P/CF
-
|
P/FCF
150.1
|
Op. Cash Flow
25.6K
|
FCF
0.3
|
|
Op. Margin
16.40%
|
Net Margin
13.60%
|
ROE
9.30%
|
ROI
7.40%
|
|
ROA
8.00%
|
EPS Growth
12.00%
|
Current Ratio
6.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Journey Medical Corp (DERM) | $4.70 | - | - | 43.3M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.00 | - | - | 5M | Strong Buy |
| Omnicell Inc (OMCL) | $44.48 | - | - | 1.32B | Strong Buy |
| Evogene Ltd (EVGN) | $3.06 | - | - | 22.7M | Strong Buy |
| Owens & Minor, Inc. (OMI) | $15.72 | - | - | 1.19B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
